Machine Learning to Predict Mortality in Older Patients With Cancer: Development and External Validation of the Geriatric Cancer Scoring System Using Two Large French Cohorts
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
View abstract on PubMed
Summary
This summary is machine-generated.A new Geriatric Cancer Scoring System (GCSS) accurately predicts mortality in older cancer patients. This machine learning tool, developed using French cohort data, aids prognosis and clinical decision-making for improved patient care.
Area Of Science
- Geriatric Oncology
- Biostatistics
- Machine Learning in Healthcare
Background
- Prognosis in older cancer patients is complex due to heterogeneity and limitations of current predictive models.
- Accurate prediction is crucial for individualized treatment and care planning in this population.
Purpose Of The Study
- To develop and externally validate the Geriatric Cancer Scoring System (GCSS) for improved mortality prediction.
- To refine individualized prognosis for older cancer patients within one year post-geriatric assessment (GA).
Main Methods
- Utilized data from two French prospective multicenter cohorts (ELCAPA and ONCODAGE) for training and validation.
- Compared Cox regression, decision tree (DT), and random survival forest (RSF) models using time-dependent area under the receiver operator curve (tAUC).
- Included oncologic, geriatric factors, and routine biomarkers as candidate predictors.
Main Results
- The random survival forest (RSF) model achieved the highest predictive performance (12-month tAUC: 0.87).
- Key predictors identified included tumor site, metastatic status, weight loss, polypharmacy, impaired function, G-8 score, and inflammatory markers (CRP/albumin).
- The Geriatric Cancer Scoring System (GCSS) was developed based on the RSF model.
Conclusions
- The GCSS, utilizing a machine learning approach, provides accurate and externally validated mortality prediction for older cancer patients.
- GCSS has the potential to enhance clinical decision-making and patient counseling following geriatric assessment.
- Further validation in international settings is recommended to confirm the generalizability of the GCSS.
Contact us if these videos are not relevant.
Contact us if these videos are not relevant.
Related Concept Videos
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...